Onderbouwing |
SWAB guideline: “Primary treatment with voriconazole or isavuconazole is recommended for patients with acute invasive aspergillosis caused by isolates with confirmed susceptibility to azoles.” [...] “For patients with invasive aspergillosis caused by isolates with unknown susceptibility to azoles, initial combination therapy with voriconazole/isavuconazole plus L-AmB, or voriconazole/isavuconazole plus an echinocandin is recommended. Monotherapy with L-AmB is considered as a second choice in these patients. In case of mixed azole-resistant and azole-susceptible mold infections, or suspected co-infection with mucorales, voriconazole/isavuconazole plus L-AmB is recommended.” |